-+ 0.00%
-+ 0.00%
-+ 0.00%

Nightingale Health Partners with Genom to Launch Blood Test in Croatia

MT Newswires·09/09/2026 08:00:37
Listen to the news
08:00 AM EDT, 09/09/2026 (MT Newswires) -- Finnish biotechnology company Nightingale Health (HEALTH.HE) and its Croatian peer Genom are partnering to deliver a blood-based risk detection test to Croatian clinics and laboratories. The Nightingale Health Check estimates a person's 10-year risk of five chronic diseases using one blood sample, according to a Wednesday release. Three pilot programs have been completed, with the companies planning to launch the test nationwide across Genom's network of clinics and labs later in 2026.